Tempest Therapeutics appointed John W. Frederick to its board of directors, enhancing its financial and capital markets expertise. Frederick brings over 30 years of executive experience in finance, operations, and strategic transformation, having held leadership roles at companies like Skillsoft and Indigo Ag. His appointment is expected to support Tempest's strategic priorities, including disciplined capital deployment and advancing its in vivo CAR-T therapy programs. This move positions Tempest for long-term growth as it develops innovative cancer and autoimmune disease treatments.
Tempest Therapeutics' board appointment news is presented with Pluang's Health sector market data as of Oct 14, 2026 19:01 WIB. Of 150 priced Health-sector US stocks tradable on Pluang, 105 rose and 40 fell today. Notable movers include GH (Guardant Health Inc. Common Stock) at USD 158.20 with a 1-day change of -2.40% and Pluang order activity of 0% Sell / 100% Buy, and XRAY (DENTSPLY SIRONA Inc) at USD 8.69 with a 1-day change of +2.18%.
BlackRock reported a strong third quarter with adjusted earnings of $15.93 per share, beating estimates by a wide margin and marking a 38% increase year-over-year. Revenue grew 19% to $7.75 billion, driven by $205 billion in net client inflows, inclu...
Home BancShares will release its Q3 2026 earnings report on October 14, with analysts expecting earnings per share of $0.64 and revenue around $293-$294 million, marking a 5.5% revenue increase and 4.9% EPS growth from last year. The bank's P/E ratio...
Hyperion Materials & Technologies has acquired The Ultra-Met Company, a tungsten carbide manufacturer based in Urbana, Ohio, to expand its capabilities in serving the US aerospace and defense sectors. Ultra-Met works closely with the US Department of...
Morgan Stanley reported Q3 earnings per share of $3.03, surpassing analyst estimates of $2.93 and $2.83 consensus. Revenue reached $20.34 billion, a 12% increase year-over-year and above the $19.93 billion estimate. Strong equity trading and record w...
Bank of New York Mellon is set to report its Q3 2026 earnings, with analysts expecting earnings per share of $2.27 and revenue of $5.55 billion. This represents an 18.3% increase in earnings and a 9.5% rise in revenue compared to the previous year, d...
